Effects of an early rehabilitation program for adult cystic fibrosis patients during hospitalization: a randomized clinical trial

Effects of an early rehabilitation program for adult cystic fibrosis patients during hospitalization: a randomized clinical trial

There is little information on pulmonary rehabilitation in patients with cystic fibrosis (CF) with pulmonary exacerbation. This study aimed to evaluate the effects of an early rehabilitation program on lung function, muscle strength, inflammatory markers, and quality of life in adults with CF hospit...

Full description

Bibliographic Details
Main Authors:	J. Flores, B. Ziegler, D. Silvello, P.T.R. Dalcin
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica 2023-08-01
Series:	Brazilian Journal of Medical and Biological Research
Subjects:	Cystic fibrosis Adults Physical exercise Pulmonary exacerbation Hospitalization
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2023000100655&lng=en&tlng=en

Similar Items

The Fitter the Better? Cardiopulmonary Exercise Testing Can Predict Pulmonary Exacerbations in Cystic Fibrosis
by: Asterios Kampouras, et al.
Published: (2021-06-01)

Lung ultrasound for the diagnosis of cystic fibrosis pulmonary exacerbation
by: Maryam Hassanzad, et al.
Published: (2021-11-01)

The association of fecal calprotectin and respiratory exacerbation in cystic fibrosis patients
by: Farid Imanzadeh, et al.
Published: (2022-11-01)

Lung Clearance Index in Children with Cystic Fibrosis during Pulmonary Exacerbation
by: Katarzyna Walicka-Serzysko, et al.
Published: (2021-10-01)

Pulmonary Exacerbations in Pediatric Patients: Retrospective Study in a Portuguese Cystic Fibrosis Center
by: Rosa Cardoso, et al.
Published: (2022-01-01)

Antimicrobial Treatment of Staphylococcus aureus in Patients With Cystic Fibrosis
by: Susanna Esposito, et al.
Published: (2019-08-01)

The Effect of Outpatient Management of Cystic Fibrosis Exacerbation on Pulmonary Function Tests: A Clinical Trial
by: Seyed Hossein Mirlohi, et al.
Published: (2022-06-01)

Time Free From Hospitalization in Children and Adolescents With Cystic Fibrosis: Findings From FEV1, Lung Clearance Index and Peak Work Rate
by: Simone Gambazza, et al.
Published: (2022-06-01)

Pharmacokinetics of Meropenem in People with Cystic Fibrosis—A Proof of Concept Clinical Trial
by: Jan C. Kamp, et al.
Published: (2021-03-01)

Role of inhaled antibiotics in children and adolescents with cystic fibrosis: Experience from the tertiary care center
by: Danish Abdul Aziz, et al.
Published: (2022-01-01)

A case of cystic fibrosis
by: Maria Alice Monti, et al.
Published: (2009-09-01)

The Impact of Antimicrobial Resistance in Cystic Fibrosis
by: Antonio Vitiello, et al.
Published: (2024-03-01)

Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives
by: Giovanni Taccetti, et al.
Published: (2021-03-01)

Pulmonary Function Tests in the Evaluation of Early Lung Disease in Cystic Fibrosis
by: Katarzyna Walicka-Serzysko, et al.
Published: (2023-07-01)

Microbial contamination of home nebulizers in children with cystic fibrosis and clinical implication on the number of pulmonary exacerbations
by: Seyed Ahmad Tabatabaii, et al.
Published: (2020-02-01)

Group B streptococcus (GBS) is an important pathogen in human disease- but what about in cystic fibrosis?
by: Kate Skolnik, et al.
Published: (2017-10-01)

The Respiratory Microbiome in Cystic Fibrosis: Compartment Patterns and Clinical Relationships in Early Stage Disease
by: Marian Garcia-Nuñez, et al.
Published: (2020-06-01)

Dyspnea perception in cystic fibrosis patients
by: B. Ziegler, et al.
Published: (2013-09-01)

Pulmonary exacerbations in early cystic fibrosis lung disease are marked by strong modulation of CD3 and PD-1 on luminal T cells
by: Vincent D. Giacalone, et al.
Published: (2023-09-01)

The Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC) trial: Rationale and design of a multi-center, double-blind, placebo-controlled trial of high dose bolus administration of vitamin D3 during acute pulmonary exacerbation of cystic fibrosis
by: Vin Tangpricha, et al.
Published: (2017-06-01)

Ceftaroline versus vancomycin for treatment of acute pulmonary exacerbations of cystic fibrosis in adults
by: Marc D. Esquivel, et al.
Published: (2022-03-01)

Association between Cystic Fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization
by: Dana Albon, et al.
Published: (2023-02-01)

Multidrug-Resistant Bacteria in Children and Adolescents with Cystic Fibrosis
by: Valentina Fainardi, et al.
Published: (2022-09-01)

Metabolomics of pulmonary exacerbations reveals the personalized nature of cystic fibrosis disease
by: Robert A. Quinn, et al.
Published: (2016-08-01)

Triplet CFTR modulators: future prospects for treatment of cystic fibrosis
by: Chaudary N
Published: (2018-12-01)

Diagnostic contribution of molecular analysis of the cystic fibrosis transmembrane conductance regulator gene in patients suspected of having mild or atypical cystic fibrosis
by: Vinícius Buaes Dal'Maso, et al.
Published: (2013-04-01)

Defects of secretion in cystic fibrosis /
by: Schultz, Carsten
Published: (2005)

Ceftolozane/Tazobactam for Treating Children With Exacerbations of Cystic Fibrosis Due to Pseudomonas aeruginosa: A Review of Available Data
by: Silvia Garazzino, et al.
Published: (2020-05-01)

The efficacy of azithromycin to prevent exacerbation of non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled studies
by: Kui Li, et al.
Published: (2022-10-01)

Impact of COVID-19 on Lung Disease in People with Cystic Fibrosis: A 6-Month Follow-Up Study on Respiratory Outcomes
by: Paola Medino, et al.
Published: (2022-11-01)

“Reactance inversion” at low frequencies in a child undergoing treatment of a cystic fibrosis exacerbation
by: Julian Lewis Allen, et al.
Published: (2019-12-01)

Investigation of respiratory rate in patients with cystic fibrosis using a minimal-impact biomotion system
by: Svenja Straßburg, et al.
Published: (2022-02-01)

Adult cystic fibrosis care in the 21st century
by: E. Garattini, et al.
Published: (2015-12-01)

Cystic fibrosis : everything you need to know /
by: 192669 Kepron, Wayne
Published: (2003)

Microbiological surveillance in patients with cystic fibrosis
by: Paola Gualdi, et al.
Published: (2010-06-01)

Features of the course and eradication of multidrug-resistant Pseudomonas aeruginosa infection in cystic fibrosis: clinical case
by: E. I. Kondratyeva, et al.
Published: (2021-10-01)

Long-term Follow-up Of Adolescent And Adult Patients With Cystic Fibrosis: A Single Center's Experience
by: Aslı İmran Yılmaz, et al.
Published: (2021-08-01)

Dynamic Hyperinflation While Exercising—A Potential Predictor of Pulmonary Deterioration in Cystic Fibrosis
by: Einat Shmueli, et al.
Published: (2023-09-01)

Isolation of Pseudomonas cepacia in cystic fibrosis patient
by: Elizabeth de Andrade Marques, et al.
Published: (1993-03-01)

Exercise Physiology Across the Lifespan in Cystic Fibrosis
by: Ren-Jay Shei, et al.
Published: (2019-11-01)